- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by ImmuneOncia Therapeutics Inc.
Total 2997 results
-
ImmuneOncia Therapeutics Inc.RecruitingAdvanced CancerKorea, Republic of
-
ImmuneOncia Therapeutics Inc.Active, not recruitingA Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal TypeExtranodal NK/T-cell Lymphoma, Nasal Type | Extranodal NK/T-cell LymphomaKorea, Republic of
-
ImmuneOncia Therapeutics Inc.CompletedLymphoma | Solid TumorKorea, Republic of, United States
-
ImmuneOncia Therapeutics Inc.CompletedSolid Tumor | Metastasis | Locally AdvancedKorea, Republic of
-
ImmuneOncia Therapeutics Inc.Not yet recruitingA Study of Phase2, IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor (TMB-H)TMB-H | Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingAdvanced Solid Tumor | Advanced Gastric Carcinoma | Advanced Cholangiocarcinoma | Advanced Lung CancerChina
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingOncology | CTLA4 HaploinsufficiencyChina
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.TerminatedHematologic MalignancyChina
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingSolid Tumor | Classic Hodgkin LymphomaChina
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Not yet recruitingB-cell Non-Hodgkin's Lymphoma
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Not yet recruiting
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingStudy of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's LymphomaCD20-positive B-cell Non-Hodgkin's LymphomaChina
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingAdvanced Breast Cancer | Advanced Solid Tumor | Advanced Gastric CancerUnited States
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.IQVIA RDSRecruiting
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Worldwide Clinical TrialsSuspendedB-cell Non-Hodgkin's LymphomaUnited States
-
Therapeutics, Inc.CompletedTinea Pedis | Tinea CrurisUnited States
-
Therapeutics, Inc.CompletedScalp PsoriasisUnited States
-
Therapeutics, Inc.CompletedAcne VulgarisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPsoriasis | Plaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedA Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)Plaque PsoriasisUnited States
-
BlackThorn Therapeutics, Inc.Neumora Therapeutics, Inc.CompletedMajor Depressive DisorderUnited States
-
Sirion Therapeutics, Inc.ReVision Therapeutics, Inc.CompletedGeographic Atrophy | Dry Age Related Macular Degeneration
-
Hoffmann-La RocheTempest Therapeutics; Adagene Inc; Immune-Onc Therapeutics; NiKang Therapeutics...RecruitingAdvanced Liver CancersKorea, Republic of, Taiwan, United States, Israel, China, France, New Zealand
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.Completed
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPsoriasis | Plaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedTinea PedisUnited States, Puerto Rico
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States, Georgia, Ukraine
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedA Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)Plaque PsoriasisUnited States
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Zhejiang Cancer Hospital; Fudan UniversityRecruitingAdvanced Solid TumorsChina
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Shandong Cancer Hospital and InstituteRecruitingBreast Cancer | Small Cell Lung Cancer | Colorectal Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Squamous Cell Cancer of Head and NeckChina
-
Cascadian Therapeutics Inc.Celldex TherapeuticsCompletedAdvanced Breast Carcinoma | Advanced Ovarian CarcinomaUnited States
-
Eikon TherapeuticsImpact Therapeutics, Inc.RecruitingAdvanced Solid TumorAustralia, United States
-
Chinook Therapeutics U.S., Inc.Active, not recruitingImmunoglobulin A Nephropathy | IgA NephropathyUnited States, Spain, Taiwan, Hong Kong, China, New Zealand, United Kingdom, Korea, Republic of, Canada, Australia, Germany, France, India, Japan, Argentina, Italy, Brazil, Colombia, Poland, Portugal
-
Millendo Therapeutics US, Inc.TerminatedCongenital Adrenal HyperplasiaSpain, Israel, France, Brazil, Czechia
-
Chinook Therapeutics U.S., Inc.Active, not recruitingDiabetic Kidney Disease | Focal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | IgA Nephropathy | Diabetic Nephropathy Type 2 | Alport SyndromeUnited States, Spain, Korea, Republic of, Australia, Italy, United Kingdom
-
Millendo Therapeutics US, Inc.TerminatedCushing SyndromeUnited States, United Kingdom
-
Bacainn Therapeutics, Inc.CompletedHealthy VolunteersUnited States
-
Chinook Therapeutics, Inc. (formerly Aduro)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
Verve Therapeutics, Inc.Not yet recruitingHypercholesterolemia
-
Aldeyra Therapeutics, Inc.RecruitingDry Eye DiseaseUnited States
-
Multitude Therapeutics Inc.Not yet recruiting
-
858 Therapeutics, Inc.RecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Advanced or Metastatic Solid Tumors | ER+ Breast Cancer | Castrate Resistant Prostate Cancer | BRCA MutationUnited States
-
Edgewise Therapeutics, Inc.RecruitingHypertrophic CardiomyopathyUnited States